Search

Corvus Pharmaceuticals Inc

Geschlossen

14.31 -6.71

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

14.74

Max

15.7

Schlüsselkennzahlen

By Trading Economics

Einkommen

-1.4M

-14M

EPS

-0.15

Angestellte

37

EBITDA

312K

-12M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+101.66% upside

Dividenden

By Acuity

Nächstes Ergebnis

6. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-71M

1.3B

Vorheriger Eröffnungskurs

21.02

Vorheriger Schlusskurs

14.31

Corvus Pharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Juli 2026, 23:56 UTC

Social Media

Electronic Arts Inc shares are lower in after-market hours, despite social media excitement for the upcoming release of EA FC 27.

13. Juli 2026, 23:56 UTC

Correlated Moves
ETF Constituents

Vanguard FTSE Europe ETF is trading lower in after-market hours, influenced by declines in top holdings and broader market sentiment amid geopolitical tensions.

13. Juli 2026, 23:56 UTC

The United States Copper Index Fund is lower in after-market trading, continuing a decline since Monday's close amid broader market weakness and rising geopolitical tensions.

13. Juli 2026, 23:56 UTC

Shares of Comcast advanced during after-market hours, reflecting modest gains since Monday's close. The broader market saw a surge in crude oil prices.

13. Juli 2026, 23:56 UTC

The US 30Y Treasury Bond Index is trading roughly flat, remaining 1.76% below its 20-day moving average amid ongoing performance weakness.

13. Juli 2026, 23:51 UTC

Geopolitical tensions spike oil prices and mixed Asian equities as investors brace for U.S. inflation data.

13. Juli 2026, 23:51 UTC

U.S. equity markets remain flat amid rising geopolitical tensions and surging crude oil prices, as investors brace for key inflation data that could impact Federal Reserve policy.

13. Juli 2026, 23:51 UTC

Global equity markets decline as U.S.-Iran tensions spike oil prices, raising inflation fears and prompting scrutiny of upcoming CPI data ahead of potential Federal Reserve policy shifts.

13. Juli 2026, 23:51 UTC

Geopolitical tensions surge as U.S.-Iran conflict raises oil prices, mixed European equities reflect cautious investor sentiment ahead of key economic data and earnings reports.

13. Juli 2026, 23:51 UTC

Australia's Consumer Confidence Index release on July 14 faces scrutiny amid rising oil prices and geopolitical tensions impacting investor sentiment.

13. Juli 2026, 23:51 UTC

Australia's Consumer Confidence Report Set for July 14, Amidst Ongoing Economic Weakness and Market Volatility.

13. Juli 2026, 23:51 UTC

Singapore's Q2 GDP Growth Forecast at 1.1% Amid Cautious Optimism and Geopolitical Risks

13. Juli 2026, 23:51 UTC

UK Retail Sales Growth Slumps to 1.7%, Falling Short of Expectations Amid Rising Political Uncertainties and Weakening Consumer Confidence

13. Juli 2026, 23:51 UTC

U.S. Initial Jobless Claims Expected at 218,000 Amid Cautious Labor Market Sentiment and Rising Inflation Concerns

13. Juli 2026, 23:51 UTC

Macro News
ETF Constituents
Correlated Moves

Materials Select Sector SPDR Fund trades roughly flat since Monday's close.

13. Juli 2026, 23:51 UTC

ProShares Ultra Bloomberg Natural Gas is trading higher in after-market hours, rebounding from earlier declines. Broader market performance remains mixed amid geopolitical tensions.

13. Juli 2026, 23:51 UTC

Social Media
Macro News
ETF Constituents

Renewed U.S.-Iran hostilities have driven crude oil prices higher, impacting global energy markets. The Energy Select Sector SPDR Fund remains roughly flat in after-market trading.

13. Juli 2026, 23:51 UTC

Correlated Moves

The CAD/JPY is higher since Friday's close, reflecting broader market sentiment and correlated movements in currency pairs like USD/JPY amid ongoing geopolitical developments.

13. Juli 2026, 23:51 UTC

Correlated Moves
Macro News

Bitcoin is trading lower amid rising geopolitical tensions affecting oil markets. The asset has declined notably since Sunday’s close, reflecting broader market concerns.

13. Juli 2026, 23:46 UTC

Shares of PayPal Holdings Inc. are lower in after-market trading, reflecting a downward trend amid broader market concerns over geopolitical tensions and oil supply disruptions.

13. Juli 2026, 23:46 UTC

ETF Constituents

Vanguard FTSE Emerging Markets ETF remains roughly flat in after-market trading. Top contributors ASX, PDD, HDB, JD, and UMC posted negative returns.

13. Juli 2026, 23:41 UTC

Correlated Moves
News
Macro News
ETF Constituents

Vanguard Information Technology ETF declined in after-market hours amid rising crude oil prices and negative sentiment from Oracle's losses, impacting major tech stocks.

13. Juli 2026, 23:41 UTC

Correlated Moves
Macro News
ETF Constituents

iShares MSCI South Korea ETF trades lower in after-market hours amid rising crude oil prices and geopolitical tensions affecting global markets.

13. Juli 2026, 23:41 UTC

Intuit Inc. shares are higher in after-market hours, continuing an upward trend. No specific company news was identified to explain the movement.

13. Juli 2026, 23:41 UTC

Charter Communications shares are roughly flat in after-market hours as inflation fears rise amid crude oil price increases and global market volatility.

13. Juli 2026, 23:41 UTC

Macro News
ETF Constituents
Correlated Moves

U.S. stocks faced pressure from rising crude oil prices amid renewed U.S.-Iran tensions. The Financial Select Sector SPDR Fund's performance remained roughly flat after market close.

13. Juli 2026, 23:41 UTC

Correlated Moves

Western Digital shares are lower in after-market hours, following a weak session amid rising crude oil prices and mixed market performance.

13. Juli 2026, 23:41 UTC

Social Media
Correlated Moves

Micron Technology Inc shares are lower in after-market hours, influenced by broader market declines and concerns over rising inflation amid surging crude oil prices.

13. Juli 2026, 23:36 UTC

abrdn Physical Palladium Shares ETF trading higher in after-market hours, fluctuating around the middle of its one-month range since Monday's close.

13. Juli 2026, 23:36 UTC

Sirius XM Holdings shares are higher in after-market hours amid volatility. The movement coincides with mixed global equity markets and rising crude oil prices.

Peer-Vergleich

Kursveränderung

Corvus Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

101.66% Vorteil

12-Monats-Prognose

Durchschnitt 31.6 USD  101.66%

Hoch 40 USD

Tief 27 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Corvus Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

5 ratings

5

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers, T cell lymphomas, autoimmune, allergic, and infectious diseases. Its lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell lymphoma, solid tumors, and atopic dermatitis. The company is also developing ciforadenant (CPI-444), an oral small molecule antagonist of the A2A receptor that is in Phase 2 clinical trial for the treatment of metastatic renal cell cancer; and mupadolimab (CPI-006), a humanized monoclonal antibody, which is in Phase 1b clinical trial for the treatment of non-small cell lung cancer and head and neck cancer. In addition, it is developing CPI-182, an antibody designed to block inflammation and myeloid suppression that is in investigational new drug application-enabling studies, as well as CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a license afreemnt with Monash University to research, develop, and commercialize certain antibodies directed to CXCR2 for the treatment of human diseases; and Vernalis (R&D) Limited to develop, manufacture, and commercialize products containing certain adenosine receptor antagonists, including ciforadenant, as well as strategic collaboration with Angel Pharmaceuticals Co. Ltd. for the development and commercialization of mupadolimab. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in Burlingame, California.
help-icon Live chat